Bayer AG (BAYN) PT Set at €125.00 by UBS AG
Bayer AG (FRA:BAYN) has been given a €125.00 ($147.06) price target by stock analysts at UBS AG in a report issued on Monday, www.boersen-zeitung.de reports. The brokerage presently has a “buy” rating on the healthcare company’s stock.
A number of other analysts have also commented on the company. Sanford C. Bernstein set a €129.00 ($151.76) price target on Bayer AG and gave the company a “buy” rating in a report on Monday. J P Morgan Chase & Co restated a “buy” rating on shares of Bayer AG in a report on Friday. Baader Bank set a €140.00 ($164.71) price target on Bayer AG and gave the company a “buy” rating in a report on Friday. Deutsche Bank AG set a €124.00 ($145.88) price target on Bayer AG and gave the company a “buy” rating in a report on Monday, October 16th. Finally, Jefferies Group LLC set a €140.00 ($164.71) price target on Bayer AG and gave the company a “buy” rating in a report on Monday, October 16th. Eight equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Bayer AG has a consensus rating of “Buy” and a consensus target price of €122.23 ($143.80).
Shares of Bayer AG (BAYN) traded down 0.475% during midday trading on Monday, reaching €117.375. The company had a trading volume of 1,019 shares. Bayer AG has a 52-week low of €85.72 and a 52-week high of €123.83. The firm has a market cap of €102.36 billion and a P/E ratio of 20.304. The company’s 50-day moving average is €113.13 and its 200-day moving average is €112.67.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.